Galenica AG
GALE
株式のランク
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
株価
$108.43
時価総額
$5.40B
変化（1日）
1.19%
変化（1年）
-3.89%
国
CH
取引 Galenica AG (GALE)
カテゴリー
Healthcare
Galenica AG（GALE）の利益
2026 時点の利益 TTM: 0
Galenica AG の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Galenica AG の利益の推移（2014 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2025 | $280.22M | 17.95% |
| 2024 | $237.57M | 2.48% |
| 2023 | $231.81M | 9.67% |
| 2022 | $211.38M | -1.81% |
| 2021 | $215.28M | -5.25% |
| 2020 | $227.21M | 34.53% |
| 2019 | $168.90M | 49.81% |
| 2018 | $112.74M | -21.46% |
| 2017 | $143.55M | 40.14% |
| 2016 | $102.44M | 2.77% |
| 2015 | $99.67M | 1.17% |
| 2014 | $98.52M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
